CAS 63610-08-2|Indobufen
Introduction:Basic information about CAS 63610-08-2|Indobufen, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Indobufen | ||
|---|---|---|---|
| CAS Number | 63610-08-2 | Molecular Weight | 295.33 |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 518.1±50.0 °C at 760 mmHg |
| Molecular Formula | C18H17NO3 | Melting Point | 33-34 °C(lit.) |
| MSDS | / | Flash Point | 267.1±30.1 °C |
Names
| Name | 2-[4-(3-oxo-1H-isoindol-2-yl)phenyl]butanoic acid |
|---|---|
| Synonym | More Synonyms |
Indobufen BiologicalActivity
| Description | Indobufen is a platelet aggregation inhibitor. Indobufen is a reversible platelet cyclooxygenase (Cox) activity inhibitor. Indobufen suppresses thromboxane A2 (TxA2) synthesis. Indobufen down-regulates tissue factor (TF) in monocytes[1]. |
|---|---|
| Related Catalog | Research Areas >>Cardiovascular DiseaseSignaling Pathways >>Immunology/Inflammation >>COX |
| Target | COX |
| In Vitro | Indobufen does not affect both Cox-1 and Cox-2 protein, whereas Indobufen reduces TxB2 levels. Indobufen inhibits TxA2 but not PGE2 synthesis in LPS-stimulated monocytes. Indobufen reduces the extent of ERK1/2 phosphorylation, whereas the levels of phosphorylated p38 are unaltered[1]. |
| References | [1]. Eligini S, et al. Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism. Cardiovasc Res. 2006 Jan;69(1):218-26. |
Chemical & Physical Properties
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 518.1±50.0 °C at 760 mmHg |
| Melting Point | 33-34 °C(lit.) |
| Molecular Formula | C18H17NO3 |
| Molecular Weight | 295.33 |
| Flash Point | 267.1±30.1 °C |
| Exact Mass | 295.120850 |
| PSA | 57.61000 |
| LogP | 3.30 |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.630 |
| InChIKey | AYDXAULLCROVIT-UHFFFAOYSA-N |
| SMILES | CCC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1 |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 373 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 345 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 333 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 697 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 365 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 370 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979
Safety Information
| WGK Germany | 3 |
|---|---|
| HS Code | 2942000000 |
Customs
| HS Code | 2918300090 |
|---|---|
| Summary | 2918300090 other carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0% |
Synonyms
| 4-(1,3-Dihydro-1-oxo-2H-isoindol-2-yl)-α-ethyl-benzeneacetic acid |
| Benzeneacetic acid, 4-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-α-ethyl-, (±)- |
| (±)-4-(1,3-Dihydro-1-oxo-2H-isoindol-2-yl)-a-ethylbenzeneacetic Acid |
| 2-[4-(1-Oxo-1,3-dihydro-isoindol-2 |
| MFCD00572250 |
| 2-[4-(1-Oxo-1,3-dihydro-2H-isoindol-2-yl)phenyl]butanoic acid |
| Benzeneacetic acid, 4-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-α-ethyl- |
| K-3920 |
| UNII-6T9949G4LZ |
| 1-Oxo-2-[p-[(a-ethyl)carboxymethyl]phenyl]isoindoline |
| EINECS 264-364-4 |
| 2-(4-(1-Oxo-2-isoindolinyl)phenyl)butyric acid |
| Ibustrin |
| 1-Oxo-2-(p-((α-ethyl)carboxymethyl)phenyl)isoindoline |
| 2-[4-(1-Carboxypropyl)phenyl]-1-isoindolinone |
| (±)-2-[p-(1-Oxo-2-isoindolinyl)phenyl]butyric Acid |
| Butyric acid, 2-(p-(1-oxo-2-isoindolinyl)phenyl)-, (±)- |
| Indobufen |
| 2-[4-(1-oxo-1,3-dihydro-isoindol-2-yl)-phenyl]-butyric acid |
| 2-(4-(1-oxoisoindolin-2-yl)phenyl)butanoic acid |
| Indobufen (INN) |
| (±)-2-(p-(1-Oxo-2-isoindolinyl)phenyl)butyric acid |
